SEYKM FINANCIAL STATEMENTS

Seyitler Kimya Sanayi A.S. — balance sheet, income statement and cash flow trends

SEYKMSeyitler Kimya Sanayi A.S.

🇹🇷 Turkey · IS · Healthcare · Medical Instruments & Supplies

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue267.9 M ₺-24.8%

Gross Profit79.6 M ₺+11.0%

Operating Income-19.6 M ₺—

EBITDA1.6 M ₺—

Net Income3.6 M ₺—

Peer Comparison· Medical Instruments & Supplies

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
SEYKM	-24.8%	29.7%	0.6%	1.3%
HBIO	-6.4%	57.1%	-2.2%	-11.4%
CTEC	6.8%	55.8%	25.3%	7.2%
EMBC	-3.4%	62.5%	30.9%	10.7%
KRMD	23.3%	61.5%	-3.4%	-5.3%
SMTI	17.4%	91.2%	7.7%	-31.2%
Industry median	6.4%	53.7%	13.8%	3.9%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
SEYKM	-24.8%	29.7%	0.6%	1.3%
TRILC	32.0%	33.8%	28.5%	-2.2%
RTALB	24.0%	35.1%	9.0%	136.3%
ANGEN	11.7%	58.8%	9.8%	-45.0%
LKMNH	19.8%	18.8%	26.4%	3.2%
MEDTR	6.5%	30.9%	9.4%	0.2%
Industry median	6.4%	53.7%	13.8%	3.9%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity573.5 M ₺88%
Current Liabilities69.9 M ₺11%
Long-term Liabilities7.2 M ₺1%

Key Figures

YoY change

Total Assets650.6 M ₺+36.9%

Total Liabilities77.1 M ₺+93.0%

Total Equity573.5 M ₺+31.8%

Cash & ST Investments270.1 M ₺+32.7%

Total Debt127.2 K ₺-89.8%

Net Debt-11.1 M ₺—

Peer Comparison· Medical Instruments & Supplies

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
SEYKM	6.82	0.0%	-168.37	88.1%
HBIO	1.99	439.2%	-19.80	12.9%
CTEC	1.53	100.0%	2.33	40.1%
EMBC	2.46	-216.9%	3.64	-60.8%
KRMD	2.33	19.9%	3.68	59.2%
SMTI	2.28	688.1%	4.17	10.1%
Industry median	2.40	34.8%	1.44	62.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
SEYKM	6.82	0.0%	-168.37	88.1%
TRILC	0.99	207.6%	2.71	23.5%
RTALB	1.21	1.2%	0.90	84.9%
ANGEN	2.31	28.1%	4.71	67.2%
LKMNH	0.83	99.0%	1.96	41.6%
MEDTR	3.58	1.0%	-1.64	83.0%
Industry median	2.40	34.8%	1.44	62.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow90 M ₺+420.0%

Capital Expenditures-8.2 M ₺—

Free Cash Flow124 M ₺+54.6%

Dividends Paid0 ₺—

Peer Comparison· Medical Instruments & Supplies

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
SEYKM	33.6%	46.3%	3.1%	2,535.7%
HBIO	3.6%	1.7%	1.9%	-31.5%
CTEC	19.1%	14.1%	4.9%	265.8%
EMBC	20.5%	19.6%	0.8%	190.8%
KRMD	1.7%	0.3%	1.3%	-31.4%
SMTI	5.9%	3.1%	2.7%	-18.8%
Industry median	13.8%	8.6%	3.8%	128.3%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
SEYKM	33.6%	46.3%	3.1%	2,535.7%
TRILC	10.9%	-0.3%	11.2%	-505.5%
RTALB	58.5%	88.6%	10.8%	42.9%
ANGEN	40.2%	-21.2%	61.5%	-89.3%
LKMNH	8.4%	-9.7%	18.2%	264.8%
MEDTR	21.1%	27.9%	6.6%	10,700.8%
Industry median	13.8%	8.6%	3.8%	128.3%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on SEYKM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.